Amin Nassar

36PUBLICATIONS
241CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 24, 2026
A Quarter Century of Transformation: Integrating Molecular Stratification and Immune Modulation Across the Continuum of Non-Small-Cell Lung Cancer.

|Jun 12, 2026
Retraction: Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.

|Apr 07, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Arianna Marinello, Julia K Rotow, Meghanne Lomibao

|Feb 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Elio Adib, Amin H Nassar, Sarah Abou Alaiwi

|Feb 18, 2026
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization.

Douglas B Johnson, Amin H Nassar, Ayesha Aijaz

|Dec 19, 2025
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

Pageof 6

Frequent Collaborators

13 joint publications

David J Kwiatkowski

13 joint publications

Toni K Choueiri

9 joint publications

Pier Vitale Nuzzo

6 joint publications

Ziad Bakouny